331 related articles for article (PubMed ID: 18433732)
1. Cytochrome P450 omega hydroxylase (CYP4) function in fatty acid metabolism and metabolic diseases.
Hardwick JP
Biochem Pharmacol; 2008 Jun; 75(12):2263-75. PubMed ID: 18433732
[TBL] [Abstract][Full Text] [Related]
2. The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review.
Leahy C; Osborne N; Shirota L; Rote P; Lee YK; Song BJ; Yin L; Zhang Y; Garcia V; Hardwick JP
Biochem Pharmacol; 2024 May; ():116241. PubMed ID: 38697309
[TBL] [Abstract][Full Text] [Related]
3. Effects of steric bulk and conformational rigidity on fatty acid omega hydroxylation by a cytochrome P450 4A1 fusion protein.
Bambal RB; Hanzlik RP
Arch Biochem Biophys; 1996 Oct; 334(1):59-66. PubMed ID: 8837739
[TBL] [Abstract][Full Text] [Related]
4. Phylogenetic and functional analyses of the cytochrome P450 family 4.
Kirischian NL; Wilson JY
Mol Phylogenet Evol; 2012 Jan; 62(1):458-71. PubMed ID: 22079551
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 4F subfamily: at the crossroads of eicosanoid and drug metabolism.
Kalsotra A; Strobel HW
Pharmacol Ther; 2006 Dec; 112(3):589-611. PubMed ID: 16926051
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 ω-Hydroxylases in Inflammation and Cancer.
Johnson AL; Edson KZ; Totah RA; Rettie AE
Adv Pharmacol; 2015; 74():223-62. PubMed ID: 26233909
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 4A fatty acid omega hydroxylases.
Okita RT; Okita JR
Curr Drug Metab; 2001 Sep; 2(3):265-81. PubMed ID: 11513330
[TBL] [Abstract][Full Text] [Related]
8. Expression of CYP4A isoforms in developing rat placental tissue and rat trophoblastic cell models.
Xu Y; Knipp GT; Cook TJ
Placenta; 2005; 26(2-3):218-25. PubMed ID: 15708123
[TBL] [Abstract][Full Text] [Related]
9. The cytochrome P450 4 (CYP4) family.
Simpson AE
Gen Pharmacol; 1997 Mar; 28(3):351-9. PubMed ID: 9068972
[TBL] [Abstract][Full Text] [Related]
10. CYP4 isoform specificity in the omega-hydroxylation of phytanic acid, a potential route to elimination of the causative agent of Refsum's disease.
Xu F; Ng VY; Kroetz DL; de Montellano PR
J Pharmacol Exp Ther; 2006 Aug; 318(2):835-9. PubMed ID: 16707724
[TBL] [Abstract][Full Text] [Related]
11. Human cytochrome P450 4F3: structure, functions, and prospects.
Corcos L; Lucas D; Le Jossic-Corcos C; Dréano Y; Simon B; Plée-Gautier E; Amet Y; Salaün JP
Drug Metabol Drug Interact; 2012 Apr; 27(2):63-71. PubMed ID: 22706230
[TBL] [Abstract][Full Text] [Related]
12. Drosophila melanogaster CYP6A8, an insect P450 that catalyzes lauric acid (omega-1)-hydroxylation.
Helvig C; Tijet N; Feyereisen R; Walker FA; Restifo LL
Biochem Biophys Res Commun; 2004 Dec; 325(4):1495-502. PubMed ID: 15555597
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of cytochrome P450 omega-hydroxylase isoforms and their association with clinicopathological features in pancreatic ductal adenocarcinoma.
Gandhi AV; Saxena S; Relles D; Sarosiek K; Kang CY; Chipitsyna G; Sendecki JA; Yeo CJ; Arafat HA
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S636-43. PubMed ID: 23846787
[TBL] [Abstract][Full Text] [Related]
14. Positional specificity of rabbit CYP4B1 for omega-hydroxylation1 of short-medium chain fatty acids and hydrocarbons.
Fisher MB; Zheng YM; Rettie AE
Biochem Biophys Res Commun; 1998 Jul; 248(2):352-5. PubMed ID: 9675139
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of rabbit small intestinal cytochromes P450 belonging to CYP2J and CYP4A subfamilies.
Koike K; Kusunose E; Nishikawa Y; Ichihara K; Inagaki S; Takagi H; Kikuta Y; Kusunose M
Biochem Biophys Res Commun; 1997 Mar; 232(3):643-7. PubMed ID: 9126328
[TBL] [Abstract][Full Text] [Related]
16. The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease.
Nakamuta M; Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Yada M; Yada R; Takemoto R; Fukuizumi K; Harada N; Taketomi A; Maehara Y; Nakashima M; Enjoji M
Int J Mol Med; 2008 Nov; 22(5):663-7. PubMed ID: 18949388
[TBL] [Abstract][Full Text] [Related]
17. Discovery, characterization, and significance of the cytochrome P450 omega-hydroxylase pathway of vitamin E catabolism.
Parker RS; Sontag TJ; Swanson JE; McCormick CC
Ann N Y Acad Sci; 2004 Dec; 1031():13-21. PubMed ID: 15753130
[TBL] [Abstract][Full Text] [Related]
18. Omega oxidation of 3-hydroxy fatty acids by the human CYP4F gene subfamily enzyme CYP4F11.
Dhar M; Sepkovic DW; Hirani V; Magnusson RP; Lasker JM
J Lipid Res; 2008 Mar; 49(3):612-24. PubMed ID: 18065749
[TBL] [Abstract][Full Text] [Related]
19. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.
Reddy JK; Rao MS
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G852-8. PubMed ID: 16603729
[TBL] [Abstract][Full Text] [Related]
20. CYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD).
Osborne N; Leahy C; Lee YK; Rote P; Song BJ; Hardwick JP
Biochem Pharmacol; 2022 Jan; 195():114841. PubMed ID: 34798124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
